Achaogen is a clinical-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of novel antibacterials to treat multi-drug resistant gram-negative i...
Achaogen is a clinical-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of novel antibacterials to treat multi-drug resistant gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients.
Public Symbol
AKAO
Founded Year
2004
Organization Website
achaogen.com
Organization Languages
English
Organization Revenue
41800
Current Technologies
ultradns
gmail
google apps
zendesk
google maps
google font api
mobile friendly
asp net
google analytics
omniture adobe
Job Functions
Consulting
Marketing
Operations
Business Development
Human Resources
Legal
Finance
Information Technology
Sales
Media And Commmunication
Support
Education
healthcare
biotechnology
health care
medical
health
wellness & fitness
hospital & health care
David Arrington's Work History and Education
Achaogen
Vice President, Investor Relations and Corporate Communications